drugset / Trial / NCT07668375
Outcome of Treatment With Botulinum toxinA in Patients With Temporomandibular Myofascial Pain
RandomizedParallel-groupDouble-blindTreatment
Summary
Purpose: The aim of this study is to investigate the effectiveness and patient reported outcomes (interincisal distance and temporomandibular myofascial pain) of treatment with intramuscularly administered BTX-A vs N/S in patients with temporomandibular myofascial pain. OBJECTIVES: To determine the outcome of treatment with botulinum toxin-A vs N/S in patients with temporomandibular myofascial pain.
Timeline
- Start
- 2026-01-02
- Primary completion
- 2026-04-01
- Completion
- 2026-04-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | letibotulinumtoxinA | Protein / enzyme biologic | 50 iu | Intramuscular |
| Subject | letibotulinumtoxinA | Protein / enzyme biologic | 100 iu | Intramuscular |